Thomas Charles Luke Sab Biotherapeutics, Inc. (SABS) insider trading activity

SABS Quotes by TradingView

Thomas Charles Luke is Chief Medical Officer of SAB Biotherapeutics, Inc.. Currently has a direct ownership of 5,428 shares of SABS, which is worth approximately $21,983. The most recent transaction as insider was on Oct 22, 2021, when has been sold 5,428 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.43K
0% 3M change
0% 12M change
Total Value Held $21,983

Thomas Charles Luke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 22 2021
BUY
Grant, award, or other acquisition
-
5,428 Added 50.0%
5,428 Common Stock
Oct 19 2021
BUY
Grant, award, or other acquisition
$9,999 $10.1 p/Share
990 Added 50.0%
990 Common Stock
TCL

Thomas Charles Luke

Chief Medical Officer
Sioux Falls, SD

Track Institutional and Insider Activities on SABS

Follow SAB Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SABS shares.

Notify only if

Insider Trading

Get notified when an Sab Biotherapeutics, Inc. insider buys or sells SABS shares.

Notify only if

News

Receive news related to SAB Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SABS